Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Hallgeir Rui MD, PhD

Hallgeir Rui MD, PhD

Professor

Institution: Medical College of Wisconsin
Department: Pathology
Division: Administration

Member of the Cancer Center


Publications

  • Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas. (Morita Y, Zhang R, Leslie M, Adhikari S, Hasan N, Chervoneva I, Rui H, Tanaka T) Oncol Lett 2017 Aug;14(2):2111-2118 PMID: 28789438 PMCID: PMC5530034 08/10/2017
  • Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment. (Katlinski KV, Gui J, Katlinskaya YV, Ortiz A, Chakraborty R, Bhattacharya S, Carbone CJ, Beiting DP, Girondo MA, Peck AR, Puré E, Chatterji P, Rustgi AK, Diehl JA, Koumenis C, Rui H, Fuchs SY) Cancer Cell 2017 Feb 13;31(2):194-207 PMID: 28196594 PMCID: PMC5313042 02/16/2017
  • E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases. (Morita Y, Kamal M, Kang SA, Zhang R, Lokesh GL, Thiviyanathan V, Hasan N, Woo S, Zhao D, Leslie M, Suh S, Razaq W, Rui H, Gorenstein DG, Volk DE, Tanaka T) Mol Ther Nucleic Acids 2016 Dec 13;5(12):e399 PMID: 27959340 12/14/2016
  • Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation. (Gui J, Gober M, Yang X, Katlinski KV, Marshall CM, Sharma M, Werth VP, Baker DP, Rui H, Seykora JT, Fuchs SY) J Invest Dermatol 2016 Oct;136(10):1990-2002 PMID: 27369778 PMCID: PMC5035634 07/03/2016
  • Erratum to: The effect of soluble E-selectin on tumor progression and metastasis. (Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh KS, Gorenstein DG, Razaq W, Rui H, Tanaka T) BMC Cancer 2016 Jun 28;16(1):370 PMID: 27353033 PMCID: PMC4926296 06/30/2016
  • Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms. (Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H) Mod Pathol 2016 Oct;29(10):1143-54 PMID: 27312066 PMCID: PMC5047958 06/18/2016
  • The effect of soluble E-selectin on tumor progression and metastasis. (Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh SK, Gorenstein DG, Razaq W, Rui H, Tanaka T) BMC Cancer 2016 May 24;16:331 PMID: 27220365 PMCID: PMC4879723 05/26/2016
  • Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression. (Katlinskaya YV, Katlinski KV, Yu Q, Ortiz A, Beiting DP, Brice A, Davar D, Sanders C, Kirkwood JM, Rui H, Xu X, Koumenis C, Diehl JA, Fuchs SY) Cell Rep 2016 Apr 05;15(1):171-80 PMID: 27052162 PMCID: PMC4826807 04/08/2016
  • Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer. (Talati PG, Gu L, Ellsworth EM, Girondo MA, Trerotola M, Hoang DT, Leiby B, Dagvadorj A, McCue PA, Lallas CD, Trabulsi EJ, Gomella L, Aplin AE, Languino L, Fatatis A, Rui H, Nevalainen MT) Am J Pathol 2015 Sep;185(9):2505-22 PMID: 26362718 PMCID: PMC4597281 09/13/2015
  • Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. (Goodman CR, Sato T, Peck AR, Girondo MA, Yang N, Liu C, Yanac AF, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H) Oncogene 2016 Mar 17;35(11):1373-85 PMID: 26096934 PMCID: PMC4800289 06/23/2015
  • Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study. (Chen Y, Bekhash A, Kovatich AJ, Hooke JA, Liu J, Kvecher L, Fantacone-Campbell JL, Mitchell EP, Rui H, Mural RJ, Shriver CD, Hu H) PLoS One 2015;10(6):e0129500 PMID: 26098961 PMCID: PMC4476726 06/23/2015
  • Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice. (Kang SA, Tsolmon B, Mann AP, Zheng W, Zhao L, Zhao YD, Volk DE, Lokesh GL, Morris L, Gupta V, Razaq W, Rui H, Suh KS, Gorenstein DG, Tanaka T) Toxicol Appl Pharmacol 2015 Aug 15;287(1):86-92 PMID: 26048585 PMCID: PMC4966538 06/07/2015
  • Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia. (Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, Fortina P, Leiby B, Xia G, Rui H, Hoang DT, Gomella LG, Cingolani G, Njar V, Pattabiraman N, Calabretta B, Nevalainen MT) Mol Cancer Ther 2015 Aug;14(8):1777-93 PMID: 26026053 PMCID: PMC4547362 05/31/2015
  • Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis. (Kang SA, Hasan N, Mann AP, Zheng W, Zhao L, Morris L, Zhu W, Zhao YD, Suh KS, Dooley WC, Volk D, Gorenstein DG, Cristofanilli M, Rui H, Tanaka T) Mol Ther 2015 Jun;23(6):1044-1054 PMID: 25815697 PMCID: PMC4817749 03/31/2015
  • The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer. (Wilson C, Lin JE, Li P, Snook AE, Gong J, Sato T, Liu C, Girondo MA, Rui H, Hyslop T, Waldman SA) Cancer Epidemiol Biomarkers Prev 2014 Nov;23(11):2328-37 PMID: 25304930 PMCID: PMC4221461 10/12/2014
  • Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury. (Bhattacharya S, Katlinski KV, Reichert M, Takano S, Brice A, Zhao B, Yu Q, Zheng H, Carbone CJ, Katlinskaya YV, Leu NA, McCorkell KA, Srinivasan S, Girondo M, Rui H, May MJ, Avadhani NG, Rustgi AK, Fuchs SY) EMBO Mol Med 2014 03;6(3):384-97 PMID: 24480543 PMCID: PMC3958312 02/01/2014
  • Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth. (Yoshida M, Selvan S, McCue PA, DeAngelis T, Baserga R, Fujii A, Rui H, Mastrangelo MJ, Sato T) Pigment Cell Melanoma Res 2014 Mar;27(2):297-308 PMID: 24354797 12/21/2013
  • NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer. (Li Q, Fu GB, Zheng JT, He J, Niu XB, Chen QD, Yin Y, Qian X, Xu Q, Wang M, Sun AF, Shu Y, Rui H, Liu LZ, Jiang BH) Biochim Biophys Acta 2013 Dec;1833(12):3375-3385 PMID: 24113386 10/12/2013
  • Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment. (Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H) Breast Cancer Res 2013;15(5):R73 PMID: 24004716 PMCID: PMC3978581 09/06/2013
  • Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer. (Chen K, Wu K, Gormley M, Ertel A, Wang J, Zhang W, Zhou J, Disante G, Li Z, Rui H, Quong AA, McMahon SB, Deng H, Lisanti MP, Wang C, Pestell RG) Oncotarget 2013 Jun;4(6):923-35 PMID: 23798621 PMCID: PMC3757249 06/27/2013
  • Global profiling of prolactin-modulated transcripts in breast cancer in vivo. (Sato T, Tran TH, Peck AR, Liu C, Ertel A, Lin J, Neilson LM, Rui H) Mol Cancer 2013 Jun 12;12:59 PMID: 23758962 PMCID: PMC3691730 06/14/2013
  • Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression. (Sato T, Tran TH, Peck AR, Girondo MA, Liu C, Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs SY, Rui H) Oncogene 2014 Apr 24;33(17):2215-24 PMID: 23708665 PMCID: PMC3913798 05/28/2013
  • STAT5A/B gene locus undergoes amplification during human prostate cancer progression. (Haddad BR, Gu L, Mirtti T, Dagvadorj A, Vogiatzi P, Hoang DT, Bajaj R, Leiby B, Ellsworth E, Blackmon S, Ruiz C, Curtis M, Fortina P, Ertel A, Liu C, Rui H, Visakorpi T, Bubendorf L, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Nevalainen MT) Am J Pathol 2013 Jun;182(6):2264-75 PMID: 23660011 PMCID: PMC3668029 05/11/2013
  • Dachshund binds p53 to block the growth of lung adenocarcinoma cells. (Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang J, Ertel A, Li Z, Rui H, Quong A, Lisanti MP, Tozeren A, Tanes C, Addya S, Gormley M, Wang C, McMahon SB, Pestell RG) Cancer Res 2013 Jun 01;73(11):3262-74 PMID: 23492369 PMCID: PMC3674204 03/16/2013
  • Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. (Lin WC, Rajbhandari N, Liu C, Sakamoto K, Zhang Q, Triplett AA, Batra SK, Opavsky R, Felsher DW, DiMaio DJ, Hollingsworth MA, Morris JP 4th, Hebrok M, Witkiewicz AK, Brody JR, Rui H, Wagner KU) Cancer Res 2013 Mar 15;73(6):1821-30 PMID: 23467612 PMCID: PMC3602120 03/08/2013
  • Population and target considerations for triple-negative breast cancer clinical trials. (Hyslop T, Michael Y, Avery T, Rui H) Biomark Med 2013 Feb;7(1):11-21 PMID: 23387481 PMCID: PMC3677035 02/08/2013
  • Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. (Myklebust MP, Li Z, Tran TH, Rui H, Knudsen ES, Elsaleh H, Fluge Ø, Vonen B, Myrvold HE, Leh S, Tveit KM, Pestell RG, Dahl O) Br J Cancer 2012 Nov 06;107(10):1684-91 PMID: 23099809 PMCID: PMC3493874 10/27/2012
  • Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. (Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH, Girondo MA, Rosenberg AL, Hooke JA, Kovatich AJ, Shriver CD, Rimm DL, Magliocco AM, Hyslop T, Rui H) Breast Cancer Res 2012 Oct 04;14(5):R130 PMID: 23036105 PMCID: PMC4053108 10/06/2012
  • Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression. (Zhang Q, Sakamoto K, Liu C, Triplett AA, Lin WC, Rui H, Wagner KU) Cancer Res 2011 Dec 15;71(24):7513-24 PMID: 22037875 PMCID: PMC3242818 11/01/2011
  • Signal transducer and activator of transcription-3 and breast cancer prognosis. (Sato T, Neilson LM, Peck AR, Liu C, Tran TH, Witkiewicz A, Hyslop T, Nevalainen MT, Sauter G, Rui H) Am J Cancer Res 2011;1(3):347-55 PMID: 21776434 PMCID: PMC3138712 07/22/2011
  • Design and Synthesis of a Fluorescently End-Labeled Poly(β-amino ester): Application to the Characterization of Degradable Polyelectrolyte Multilayers. (Bechler SL, Lynn DM) J Polym Sci A Polym Chem 2011 Apr 01;49(7):1572-1581 PMID: 21666772 PMCID: PMC3110734 06/15/2011
  • Inflammatory signaling compromises cell responses to interferon alpha. (Huangfu WC, Qian J, Liu C, Liu J, Lokshin AE, Baker DP, Rui H, Fuchs SY) Oncogene 2012 Jan 12;31(2):161-72 PMID: 21666722 PMCID: PMC3175348 06/15/2011
  • Melanoma cell-secreted soluble factor that stimulates ubiquitination and degradation of the interferon alpha receptor and attenuates its signaling. (HuangFu WC, Qian J, Liu C, Rui H, Fuchs SY) Pigment Cell Melanoma Res 2010 Dec;23(6):838-40 PMID: 21644263 PMCID: PMC3688261 06/07/2011
  • Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. (Peck AR, Witkiewicz AK, Liu C, Stringer GA, Klimowicz AC, Pequignot E, Freydin B, Tran TH, Yang N, Rosenberg AL, Hooke JA, Kovatich AJ, Nevalainen MT, Shriver CD, Hyslop T, Sauter G, Rimm DL, Magliocco AM, Rui H) J Clin Oncol 2011 Jun 20;29(18):2448-58 PMID: 21576635 PMCID: PMC3675698 05/18/2011
  • Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. (Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y, Zou C, Zhang X, Liu S, Wang X, Zhao D, Sun Q, Zeng Z, Dress A, Lin MC, Kung HF, Rui H, Liu LZ, Mao F, Jiang BH, Lai L) Clin Cancer Res 2011 Apr 01;17(7):1722-30 PMID: 21350001 02/26/2011
  • Differential expression of arrestins is a predictor of breast cancer progression and survival. (Michal AM, Peck AR, Tran TH, Liu C, Rimm DL, Rui H, Benovic JL) Breast Cancer Res Treat 2011 Dec;130(3):791-807 PMID: 21318602 PMCID: PMC3156829 02/15/2011
  • Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. (Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA) Breast Cancer Res 2011 Jan 28;13(1):R11 PMID: 21276249 PMCID: PMC3109579 02/01/2011
  • Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma. (Behling KC, Tang A, Freydin B, Chervoneva I, Kadakia S, Schwartz GF, Rui H, Witkiewicz AK) Breast Cancer Res Treat 2011 Oct;129(3):717-24 PMID: 21088888 PMCID: PMC3730842 11/23/2010
  • Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferation. (Varghese B, Swaminathan G, Plotnikov A, Tzimas C, Yang N, Rui H, Fuchs SY) Mol Endocrinol 2010 Dec;24(12):2356-65 PMID: 20962042 PMCID: PMC2999476 10/22/2010
  • PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. (Johnson KJ, Peck AR, Liu C, Tran TH, Utama FE, Sjolund AB, Schaber JD, Witkiewicz AK, Rui H) Am J Pathol 2010 Dec;177(6):2971-83 PMID: 20952588 PMCID: PMC2993292 10/19/2010
  • RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response. (Ertel A, Dean JL, Rui H, Liu C, Witkiewicz AK, Knudsen KE, Knudsen ES) Cell Cycle 2010 Oct 15;9(20):4153-63 PMID: 20948315 PMCID: PMC3055199 10/16/2010
  • N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells. (Dagvadorj A, Tan SH, Liao Z, Xie J, Nurmi M, Alanen K, Rui H, Mirtti T, Nevalainen MT) Int J Biochem Cell Biol 2010 Dec;42(12):2037-46 PMID: 20854925 PMCID: PMC2982800 09/22/2010
  • HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients. (Richards NG, Rittenhouse DW, Freydin B, Cozzitorto JA, Grenda D, Rui H, Gonye G, Kennedy EP, Yeo CJ, Brody JR, Witkiewicz AK) Ann Surg 2010 Sep;252(3):499-505; discussion 505-6 PMID: 20739850 08/27/2010
  • Protocol for constructing tissue arrays by cutting edge matrix assembly. (Tran TH, Lin J, Sjolund AB, Utama FE, Rui H) Methods Mol Biol 2010;664:45-52 PMID: 20690051 08/07/2010
  • Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence. (Witkiewicz AK, Freydin B, Chervoneva I, Potoczek M, Rizzo W, Rui H, Brody JR, Schwartz GF, Lisanti MP) Cancer Biol Ther 2010 Aug 15;10(4):391-6 PMID: 20574156 PMCID: PMC3040854 06/25/2010
  • Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. (Tran TH, Utama FE, Lin J, Yang N, Sjolund AB, Ryder A, Johnson KJ, Neilson LM, Liu C, Brill KL, Rosenberg AL, Witkiewicz AK, Rui H) Cancer Res 2010 Feb 15;70(4):1711-21 PMID: 20124477 PMCID: PMC2822876 02/04/2010
  • STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells. (Nagy ZS, LeBaron MJ, Ross JA, Mitra A, Rui H, Kirken RA) Mol Cancer 2009 Aug 26;8:67 PMID: 19709433 PMCID: PMC2741462 08/28/2009
  • Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. (Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, Sutherland RL, Knudsen KE) Clin Cancer Res 2009 Sep 01;15(17):5338-49 PMID: 19706803 PMCID: PMC2849314 08/27/2009
  • Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes. (Arendt LM, Evans LC, Rugowski DE, Garcia-Barchino MJ, Rui H, Schuler LA) J Endocrinol 2009 Oct;203(1):99-110 PMID: 19635758 PMCID: PMC2841967 07/29/2009
  • The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. (Popov VM, Zhou J, Shirley LA, Quong J, Yeow WS, Wright JA, Wu K, Rui H, Vadlamudi RK, Jiang J, Kumar R, Wang C, Pestell RG) Cancer Res 2009 Jul 15;69(14):5752-60 PMID: 19605405 PMCID: PMC3244171 07/17/2009
  • Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer. (Witkiewicz AK, Dasgupta A, Nguyen KH, Liu C, Kovatich AJ, Schwartz GF, Pestell RG, Sotgia F, Rui H, Lisanti MP) Cancer Biol Ther 2009 Jun;8(11):1071-9 PMID: 19502809 06/09/2009
  • Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. (Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, Rui H, Pestell RG, Lisanti MP) Am J Pathol 2009 Apr;174(4):1172-90 PMID: 19342371 PMCID: PMC2671351 04/04/2009
  • Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome. (Millar EK, Dean JL, McNeil CM, O'Toole SA, Henshall SM, Tran T, Lin J, Quong A, Comstock CE, Witkiewicz A, Musgrove EA, Rui H, Lemarchand L, Setiawan VW, Haiman CA, Knudsen KE, Sutherland RL, Knudsen ES) Oncogene 2009 Apr 16;28(15):1812-20 PMID: 19287456 PMCID: PMC3073345 03/17/2009
  • Impaired turnover of prolactin receptor contributes to transformation of human breast cells. (Plotnikov A, Varghese B, Tran TH, Liu C, Rui H, Fuchs SY) Cancer Res 2009 Apr 01;69(7):3165-72 PMID: 19276348 PMCID: PMC2664855 03/12/2009
  • Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. (Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, Milliman JN, Knudsen ES, Zhou J, Wang C, Pestell RG, Lisanti MP) Am J Pathol 2009 Feb;174(2):613-29 PMID: 19164602 PMCID: PMC2630569 01/24/2009
  • Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells. (Utama FE, Tran TH, Ryder A, LeBaron MJ, Parlow AF, Rui H) Endocrinology 2009 Apr;150(4):1782-90 PMID: 19022890 PMCID: PMC2659276 11/22/2008
  • ErbB2 induces Notch1 activity and function in breast cancer cells. (Lindsay J, Jiao X, Sakamaki T, Casimiro MC, Shirley LA, Tran TH, Ju X, Liu M, Li Z, Wang C, Katiyar S, Rao M, Allen KG, Glazer RI, Ge C, Stanley P, Lisanti MP, Rui H, Pestell RG) Clin Transl Sci 2008 Sep;1(2):107-15 PMID: 20443831 PMCID: PMC3590841 09/01/2008
  • Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. (Wang Y, Dean JL, Millar EK, Tran TH, McNeil CM, Burd CJ, Henshall SM, Utama FE, Witkiewicz A, Rui H, Sutherland RL, Knudsen KE, Knudsen ES) Cancer Res 2008 Jul 15;68(14):5628-38 PMID: 18632615 07/18/2008
  • Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor. (Plotnikov A, Li Y, Tran TH, Tang W, Palazzo JP, Rui H, Fuchs SY) Cancer Res 2008 Mar 01;68(5):1354-61 PMID: 18316598 03/05/2008
  • Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression. (Wagner KU, Rui H) J Mammary Gland Biol Neoplasia 2008 Mar;13(1):93-103 PMID: 18228120 01/30/2008
  • Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways. (Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner KU, Kirken RA, Rui H) Mol Endocrinol 2007 Sep;21(9):2218-32 PMID: 17550976 06/07/2007
  • Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells. (Dalmizrak O, Wu A, Chen J, Sun H, Utama FE, Zambelli D, Tran TH, Rui H, Baserga R) Cancer Res 2007 Mar 01;67(5):2124-30 PMID: 17332342 03/03/2007
  • In vivo response-based identification of direct hormone target cell populations using high-density tissue arrays. (LeBaron MJ, Ahonen TJ, Nevalainen MT, Rui H) Endocrinology 2007 Mar;148(3):989-1008 PMID: 17138649 12/02/2006
  • Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers. (Sotgia F, Rui H, Bonuccelli G, Mercier I, Pestell RG, Lisanti MP) Cancer Res 2006 Nov 15;66(22):10647-51 PMID: 17108100 11/17/2006
  • Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. (Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, Capozza F, Mercier I, Rui H, Pestell RG, Lisanti MP) Am J Pathol 2006 Nov;169(5):1784-801 PMID: 17071600 PMCID: PMC1780215 10/31/2006
  • A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor. (Nagy ZS, Rui H, Stepkowski SM, Karras J, Kirken RA) J Immunol 2006 Oct 15;177(8):5032-40 PMID: 17015686 10/04/2006
  • Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. (Utama FE, LeBaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner KU, Rui H) J Endocrinol 2006 Mar;188(3):589-601 PMID: 16522738 03/09/2006
  • Creating tissue microarrays by cutting-edge matrix assembly. (Rui H, LeBaron MJ) Expert Rev Med Devices 2005 Nov;2(6):673-80 PMID: 16293094 11/19/2005
  • The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells. (Selliah N, Zhang M, DeSimone D, Kim H, Brunner M, Ittenbach RF, Rui H, Cron RQ, Finkel TH) Virology 2006 Jan 20;344(2):283-91 PMID: 16289657 11/18/2005
  • Ultrahigh density microarrays of solid samples. (LeBaron MJ, Crismon HR, Utama FE, Neilson LM, Sultan AS, Johnson KJ, Andersson EC, Rui H) Nat Methods 2005 Jul;2(7):511-3 PMID: 15973421 06/24/2005
  • Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. (LeBaron MJ, Xie J, Rui H) Mol Cancer 2005 Feb 01;4(1):6 PMID: 15686596 PMCID: PMC549029 02/03/2005
  • Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. (Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H) Oncogene 2005 Jan 27;24(5):746-60 PMID: 15592524 12/14/2004
  • Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice. (Krempler A, Qi Y, Triplett AA, Zhu J, Rui H, Wagner KU) Genesis 2004 Sep;40(1):52-7 PMID: 15354294 09/09/2004
  • Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. (Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H) Mol Cell Biol 2004 Jun;24(12):5510-20 PMID: 15169911 PMCID: PMC419899 06/01/2004
  • Signal transducer and activator of transcription-5 activation and breast cancer prognosis. (Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H) J Clin Oncol 2004 Jun 01;22(11):2053-60 PMID: 15169792 06/01/2004
  • Role of Stat5 in type I interferon-signaling and transcriptional regulation. (Uddin S, Lekmine F, Sassano A, Rui H, Fish EN, Platanias LC) Biochem Biophys Res Commun 2003 Aug 22;308(2):325-30 PMID: 12901872 08/07/2003
  • Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells. (Ahonen TJ, Xie J, LeBaron MJ, Zhu J, Nurmi M, Alanen K, Rui H, Nevalainen MT) J Biol Chem 2003 Jul 18;278(29):27287-92 PMID: 12719422 04/30/2003
  • STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA. (Benitah SA, Valerón PF, Rui H, Lacal JC) Mol Biol Cell 2003 Jan;14(1):40-53 PMID: 12529425 PMCID: PMC140226 01/17/2003
  • Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways. (Nagy ZS, Wang Y, Erwin-Cohen RA, Aradi J, Monia B, Wang LH, Stepkowski SM, Rui H, Kirken RA) J Leukoc Biol 2002 Oct;72(4):819-28 PMID: 12377952 10/16/2002
  • Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB. (Boer AK, Drayer AL, Rui H, Vellenga E) Blood 2002 Jul 15;100(2):467-73 PMID: 12091337 07/02/2002
  • Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. (Nevalainen MT, Xie J, Bubendorf L, Wagner KU, Rui H) Mol Endocrinol 2002 May;16(5):1108-24 PMID: 11981045 05/01/2002
  • Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. (Xie J, LeBaron MJ, Nevalainen MT, Rui H) J Biol Chem 2002 Apr 19;277(16):14020-30 PMID: 11821424 02/01/2002
  • PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro. (Ahonen TJ, Härkönen PL, Rui H, Nevalainen MT) Endocrinology 2002 Jan;143(1):228-38 PMID: 11751614 12/26/2001
  • Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity. (Park SH, Yamashita H, Rui H, Waxman DJ) Mol Endocrinol 2001 Dec;15(12):2157-71 PMID: 11731617 12/04/2001
  • Role of serine phosphorylation of Stat5a in prolactin-stimulated beta-casein gene expression. (Yamashita H, Nevalainen MT, Xu J, LeBaron MJ, Wagner KU, Erwin RA, Harmon JM, Hennighausen L, Kirken RA, Rui H) Mol Cell Endocrinol 2001 Oct 25;183(1-2):151-63 PMID: 11604235 10/18/2001
  • Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells. (Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL) J Immunol 2000 Nov 01;165(9):5097-104 PMID: 11046040 10/25/2000
  • Epithelial defect in prostates of Stat5a-null mice. (Nevalainen MT, Ahonen TJ, Yamashita H, Chandrashekar V, Bartke A, Grimley PM, Robinson GW, Hennighausen L, Rui H) Lab Invest 2000 Jul;80(7):993-1006 PMID: 10908145 07/25/2000
  • Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. (Grimley PM, Dong F, Rui H) Cytokine Growth Factor Rev 1999 Jun;10(2):131-57 PMID: 10743504 04/01/2000
  • Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture. (Ahonen TJ, Härkönen PL, Laine J, Rui H, Martikainen PM, Nevalainen MT) Endocrinology 1999 Nov;140(11):5412-21 PMID: 10537173 10/28/1999
  • A lymphoma growth inhibitor blocks some but not all prolactin-stimulated signaling pathways. (Yamashita H, Xu J, Erwin RA, Larner AC, Rui H) J Biol Chem 1999 May 21;274(21):14699-705 PMID: 10329665 05/18/1999
  • Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells. (Yamashita H, Xu J, Erwin RA, Farrar WL, Kirken RA, Rui H) J Biol Chem 1998 Nov 13;273(46):30218-24 PMID: 9804779 11/07/1998
  • Prolonged STAT1 activation related to the growth arrest of malignant lymphoma cells by interferon-alpha. (Grimley PM, Fang H, Rui H, Petricoin EF 3rd, Ray S, Dong F, Fields KH, Hu R, Zoon KC, Audet S, Beeler J) Blood 1998 Apr 15;91(8):3017-27 PMID: 9531615 05/16/1998
  • Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells. (Schaber JD, Fang H, Xu J, Grimley PM, Rui H) Cancer Res 1998 May 01;58(9):1914-9 PMID: 9581833 05/15/1998
  • Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid. (Rui H, Xu J, Mehta S, Fang H, Williams J, Dong F, Grimley PM) J Biol Chem 1998 Jan 02;273(1):28-32 PMID: 9417042 02/07/1998
  • Two discrete regions of interleukin-2 (IL2) receptor beta independently mediate IL2 activation of a PD98059/rapamycin/wortmannin-insensitive Stat5a/b serine kinase. (Kirken RA, Malabarba MG, Xu J, DaSilva L, Erwin RA, Liu X, Hennighausen L, Rui H, Farrar WL) J Biol Chem 1997 Jun 13;272(24):15459-65 PMID: 9182578 06/13/1997
  • Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple Stat5 isoforms in Nb2 lymphocytes. (Kirken RA, Malabarba MG, Xu J, Liu X, Farrar WL, Hennighausen L, Larner AC, Grimley PM, Rui H) J Biol Chem 1997 May 30;272(22):14098-103 PMID: 9162035 05/30/1997
  • Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha. (Malabarba MG, Rui H, Deutsch HH, Chung J, Kalthoff FS, Farrar WL, Kirken RA) Biochem J 1996 Nov 01;319 ( Pt 3):865-72 PMID: 8920992 PMCID: PMC1217868 11/01/1996
  • Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580. (DaSilva L, Rui H, Erwin RA, Howard OM, Kirken RA, Malabarba MG, Hackett RH, Larner AC, Farrar WL) Mol Cell Endocrinol 1996 Mar 25;117(2):131-40 PMID: 8737372 03/25/1996
  • Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. (Kirken RA, Rui H, Malabarba MG, Howard OM, Kawamura M, O'Shea JJ, Farrar WL) Cytokine 1995 Oct;7(7):689-700 PMID: 8580378 10/01/1995
  • Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. (Erwin RA, Kirken RA, Malabarba MG, Farrar WL, Rui H) Endocrinology 1995 Aug;136(8):3512-8 PMID: 7628388 08/01/1995
  • Cloning of the gene encoding rat JAK2, a protein tyrosine kinase. (Duhé RJ, Rui H, Greenwood JD, Garvey K, Farrar WL) Gene 1995 Jun 09;158(2):281-5 PMID: 7607555 06/09/1995
  • Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha. (Malabarba MG, Kirken RA, Rui H, Koettnitz K, Kawamura M, O'Shea JJ, Kalthoff FS, Farrar WL) J Biol Chem 1995 Apr 21;270(16):9630-7 PMID: 7721895 04/21/1995
  • Effects of growth hormone and prolactin immune development and function. (Murphy WJ, Rui H, Longo DL) Life Sci 1995;57(1):1-14 PMID: 7596216 01/01/1995
  • [Male infertility. Significance of life and occupation]. (Oldereid NB, Rui H, Purvis K) Tidsskr Nor Laegeforen 1994 Nov 20;114(28):3308-11 PMID: 7809887 11/20/1994
  • JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. (Rui H, Lebrun JJ, Kirken RA, Kelly PA, Farrar WL) Endocrinology 1994 Oct;135(4):1299-306 PMID: 7925093 10/01/1994
  • Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. (Kirken RA, Rui H, Malabarba MG, Farrar WL) J Biol Chem 1994 Jul 22;269(29):19136-41 PMID: 7518451 07/22/1994
  • Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. (DaSilva L, Howard OM, Rui H, Kirken RA, Farrar WL) J Biol Chem 1994 Jul 15;269(28):18267-70 PMID: 8034567 07/15/1994
  • Activation of receptor-associated tyrosine kinase JAK2 by prolactin. (Rui H, Kirken RA, Farrar WL) J Biol Chem 1994 Feb 18;269(7):5364-8 PMID: 7508935 02/18/1994
  • Involvement of JAK-family tyrosine kinases in hematopoietin receptor signal transduction. (Kirken RA, Rui H, Howard OM, Farrar WL) Prog Growth Factor Res 1994;5(2):195-211 PMID: 7919224 01/01/1994
  • Characterization of an interleukin-2 (IL-2)-induced tyrosine phosphorylated 116-kDa protein associated with the IL-2 receptor beta-subunit. (Kirken RA, Rui H, Evans GA, Farrar WL) J Biol Chem 1993 Oct 25;268(30):22765-70 PMID: 7693677 10/25/1993
  • Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. (Djeu JY, Liu JH, Wei S, Rui H, Pearson CA, Leonard WJ, Blanchard DK) J Immunol 1993 Feb 01;150(3):960-70 PMID: 8380826 02/01/1993
  • The value of anamnestic information regarding previous genital infection in male fertility investigation. (Oldereid NB, Rui H, Purvis K) Eur J Obstet Gynecol Reprod Biol 1992 Dec 28;47(3):207-12 PMID: 1294407 12/28/1992
  • Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. (Rui H, Djeu JY, Evans GA, Kelly PA, Farrar WL) J Biol Chem 1992 Nov 25;267(33):24076-81 PMID: 1385436 11/25/1992
  • Life styles of men in barren couples and their relationship to sperm quality. (Oldereid NB, Rui H, Purvis K) Int J Fertil 1992 Nov-Dec;37(6):343-9 PMID: 1360454 11/01/1992
  • Lifestyles of men in barren couples and their relationships to sperm quality. (Oldereid NB, Rui H, Purvis K) Eur J Obstet Gynecol Reprod Biol 1992 Jan 09;43(1):51-7 PMID: 1737609 01/09/1992
  • Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia. (Purvis K, Tollefsrud A, Rui H, Haug E, Norseth J, Viksmoen L, Ose L, Lund H) Eur J Clin Pharmacol 1992;42(1):61-4 PMID: 1541317 01/01/1992
  • Prolactin activates protein kinase C and stimulates growth-related gene expression in rat liver. (Crowe PD, Buckley AR, Zorn NE, Rui H) Mol Cell Endocrinol 1991 Aug;79(1-3):29-35 PMID: 1718797 08/01/1991
  • [Infertility studies in men]. (Oldereid NB, Rui H, Purvis K) Tidsskr Nor Laegeforen 1991 Apr 20;111(10):1265-8 PMID: 2042142 04/20/1991
  • Male partners in infertile couples. Personal attitudes and contact with the Norwegian health service. (Oldereid NB, Rui H, Purvis K) Scand J Soc Med 1990 Sep;18(3):207-11 PMID: 2237329 09/01/1990
  • Application of flow cytometry to studies on the human acrosome. (Purvis K, Rui H, Schølberg A, Hesla S, Clausen OP) J Androl 1990 Jul-Aug;11(4):361-6 PMID: 2211342 07/01/1990
  • Polyamines and other accessory sex gland secretions in human seminal plasma 8 years after vasectomy. (Jakobsen H, Rui H, Thomassen Y, Hald T, Purvis K) J Reprod Fertil 1989 Sep;87(1):39-45 PMID: 2621711 09/01/1989
  • Cigarette smoking and human sperm quality assessed by laser-Doppler spectroscopy and DNA flow cytometry. (Oldereid NB, Rui H, Clausen OP, Purvis K) J Reprod Fertil 1989 Jul;86(2):731-6 PMID: 2760898 07/01/1989
  • Stability of sperm characteristics in men with disturbances in sperm quality. (Purvis K, Tollefsrud A, Rui H) Int J Androl 1989 Jun;12(3):171-8 PMID: 2767777 06/01/1989
  • Sperm adenylyl cyclase in young and middle-aged men. (Rui H, Purvis K, Gordeladze JO) Andrologia 1989 Mar-Apr;21(2):131-5 PMID: 2712367 03/01/1989
  • [Smoking and sperm quality in men undergoing fertility studies]. (Rui H, Oldereid NB, Purvis K) Tidsskr Nor Laegeforen 1989 Feb 20;109(5):573-5 PMID: 2922717 02/20/1989
  • Correlates of human sperm motility assessed by laser Doppler spectroscopy. (Purvis K, Tollefsrud A, Rui H) Int J Androl 1989 Feb;12(1):10-6 PMID: 2714870 02/01/1989
  • Distribution of Thyroliberin (TRH)- and 12-O-tetradecanoylphorbol 13-acetate (TPA)-activated adenylyl cyclase in normal and neoplastic tissue with special reference to the prostate. (Gordeladze JO, Rur H, Attramadal A, Tveter K, Gautvik KM, Purvis K) Mol Cell Endocrinol 1988 Aug;58(2-3):287-90 PMID: 3145232 08/01/1988
  • [Sperm motility. Physiology, analytical methods and clinical aspects]. (Purvis K, Attramadal A, Rui H, Tollefsrud A, Abyholm T, Magnus O) Tidsskr Nor Laegeforen 1988 May 20;108(14):1128-32 PMID: 3388340 05/20/1988
  • Hormonal control of prostate function. (Rui H, Purvis K) Scand J Urol Nephrol Suppl 1988;107:32-8 PMID: 2897713 01/01/1988
  • Secretory function of the prostate gland. (Purvis K, Attramadal A, Rui H) Scand J Urol Nephrol Suppl 1988;107:46-51 PMID: 3287597 01/01/1988
  • High-affinity, calmodulin-dependent isoforms of cyclic nucleotide phosphodiesterase in rat testis. (Purvis K, Rui H) Methods Enzymol 1988;159:675-85 PMID: 2842629 01/01/1988
  • Prostatic secretory products as markers of prostatic neoplasms. (Purvis K, Mevåg B, Teige B, Torjesen P, Jakobsen H, Rui H, Attramadal A) APMIS Suppl 1988;2:224-37 PMID: 2460112 01/01/1988
  • Thyrotrophin-releasing hormone in human ejaculate. (Rui H, Welinder BS, Purvis K, Dolva O) J Endocrinol 1987 Aug;114(2):329-34 PMID: 3116142 08/01/1987
  • Independent control of citrate production and ornithine decarboxylase by prolactin in the lateral lobe of the rat prostate. (Rui H, Purvis K) Mol Cell Endocrinol 1987 Jul;52(1-2):91-5 PMID: 3114026 07/01/1987
  • Androgen interaction with the polyamine system of the rat prostate. (Rui H, Brekke I, Mørkås L, Purvis K) Andrologia 1987 Mar-Apr;19(2):134-42 PMID: 3688484 03/01/1987
  • Prolactin selectively stimulates ornithine decarboxylase in the lateral lobe of the rat prostate. (Rui H, Purvis K) Mol Cell Endocrinol 1987 Mar;50(1-2):89-97 PMID: 3582728 03/01/1987
  • Further observations on the autoregulation of the prolactin receptor in rat ventral prostate explants. (Rui H, Brekke I, Torjesen PA, Purvis K) Acta Endocrinol (Copenh) 1987 Mar;114(3):426-32 PMID: 3551431 03/01/1987
  • 5 Alpha-reductase in the non-secretory cells of the rat ventral prostate epithelium. (Purvis K, Brekke I, Rui H, Sunde A) J Steroid Biochem 1986 Dec;25(6):1023-5 PMID: 3795950 12/01/1986
  • Ejaculate composition after masturbation and coitus in the human male. (Purvis K, Magnus O, Mørkås L, Abyholm T, Rui H) Int J Androl 1986 Dec;9(6):401-6 PMID: 3553035 12/01/1986
  • Effects of oestrogen-induced hyperprolactinemia on the rat prostate. (Oldereid NB, Thomassen Y, Rui H, Gordeladze JO, Haug E, Purvis K) Andrologia 1986 Sep-Oct;18(5):516-22 PMID: 3800010 09/01/1986
  • Short-term effects of mating on the accessory sex glands of the male rat. (Purvis K, Haug E, Thomassen Y, Mevåg B, Rui H) J Reprod Fertil 1986 Jul;77(2):373-80 PMID: 3735239 07/01/1986
  • Time- and temperature-related alterations in seminal plasma constituents after ejaculation. (Rui H, Mørkås L, Purvis K) Int J Androl 1986 Jun;9(3):195-200 PMID: 3804465 06/01/1986
  • Homologous up-regulation of the prolactin receptor in rat prostatic explants. (Rui H, Brekke I, Torjesen PA, Purvis K) Mol Cell Endocrinol 1986 Jun;46(1):53-7 PMID: 3011565 06/01/1986
  • Accessory sex gland function in normal young (20-25 years) and middle-aged (50-55 years) men. (Rui H, Thomassen Y, Oldereid NB, Purvis K) J Androl 1986 Mar-Apr;7(2):93-9 PMID: 3957786 03/01/1986
  • Biochemical correlates of asthenozoospermia: a lesion at the level of the sperm adenylyl cyclase. (Magnus O, Purvis K, Rui H, Clausen OP, Abyholm T, Gordeladze JO) Arch Androl 1986;17(3):165-72 PMID: 3606270 01/01/1986
  • Hormonal activation of the adenylyl cyclases of the rat and human prostate gland. (Purvis K, Rui H, Gordeladze JO, Attramadal H) Prostate 1986;8(1):11-24 PMID: 2418428 01/01/1986
  • Short-term effects of prolactin on prostatic function in rats with lisuride-induced hypoprolactinaemia. (Rui H, Haug E, Mevåg B, Thomassen Y, Purvis K) J Reprod Fertil 1985 Nov;75(2):421-32 PMID: 4067923 11/01/1985
  • Circadian rhythms in accessory sex gland function in the male rat. (Rui H, Gordeladze JO, Mevåg B, Haug E, Brekke I, Purvis K) Urol Int 1985;40(6):331-6 PMID: 4090105 01/01/1985
  • Estrogen receptors in stromal and epithelial fractions of the ventral prostate of rats. (Purvis K, Mørkås L, Rui H, Attramadal A) Arch Androl 1985;15(2-3):143-51 PMID: 3833071 01/01/1985
  • Testicular and glandular contributions to the prolactin pool in human semen. (Rui H, Torjesen PA, Jacobsen H, Purvis K) Arch Androl 1985;15(2-3):129-36 PMID: 3833069 01/01/1985
  • Two-dimensional electrophoresis of proteins in various fractions of the human split ejaculate. (Rui H, Mevåg B, Purvis K) Int J Androl 1984 Dec;7(6):509-20 PMID: 6526515 12/01/1984
  • Prolactin desensitizes the prostaglandin E1-dependent adenylyl cyclase in the rat prostate gland. (Rui H, Gordeladze JO, Gautvik KM, Purvis K) Mol Cell Endocrinol 1984 Nov;38(1):53-60 PMID: 6542888 11/01/1984
  • Seminal plasma characteristics during frequent ejaculation. (Rui H, Gerhardt P, Mevåg B, Thomassen Y, Purvis K) Int J Androl 1984 Apr;7(2):119-28 PMID: 6724722 04/01/1984
  • Current approaches to research on prostatic function and pathology. (Purvis K, Rui H, Attramadal A, Tveter KJ) Eur Surg Res 1984;16 Suppl 2:88-101 PMID: 6202522 01/01/1984
  • [Attitude to death and terminal care in Norway]. (Rui H, Bjørnland K, Skipenes G, Haugen K, Purvis K) Tidsskr Nor Laegeforen 1982 Nov 10;102(31):1625-9 PMID: 7167929 11/10/1982
  • Last update: 08/11/2017
    jenkins-FCD Prod-132 e0edc266de37dd13c3a3aec79eb87f3c7abc6fa4